Dec 22, 2008 - Biovail Corporation today announced that a subsidiary, Biovail Laboratories International SRL, has entered into a supply agreement with sanofi aventis US for the marketing and distribution of Aplenzin (bupropion hydrobromide tablets) in the United States and Puerto Rico.
The details can be read here.
No comments:
Post a Comment